- Home
- COP vs PFE Comparison
COP vs PFE Comparison
Compare COP & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COP
- PFE
- Stock Information
- Founded
- COP 1917
- PFE 1849
- Country
- COP United States
- PFE United States
- Employees
- COP N/A
- PFE N/A
- Industry
- COP Integrated oil Companies
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- COP Energy
- PFE Health Care
- Exchange
- COP Nasdaq
- PFE Nasdaq
- Market Cap
- COP 119.9B
- PFE 134.2B
- IPO Year
- COP N/A
- PFE N/A
- Fundamental
- Price
- COP $95.57
- PFE $25.65
- Analyst Decision
- COP Buy
- PFE Hold
- Analyst Count
- COP 18
- PFE 14
- Target Price
- COP $120.06
- PFE $29.92
- AVG Volume (30 Days)
- COP 8.9M
- PFE 39.0M
- Earning Date
- COP 08-07-2025
- PFE 08-05-2025
- Dividend Yield
- COP 3.27%
- PFE 6.71%
- EPS Growth
- COP N/A
- PFE N/A
- EPS
- COP 7.91
- PFE 1.38
- Revenue
- COP $59,090,000,000.00
- PFE $62,464,000,000.00
- Revenue This Year
- COP $7.63
- PFE N/A
- Revenue Next Year
- COP $1.76
- PFE N/A
- P/E Ratio
- COP $12.08
- PFE $18.54
- Revenue Growth
- COP 4.00
- PFE 11.65
- 52 Week Low
- COP $79.88
- PFE $20.92
- 52 Week High
- COP $118.40
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- COP 58.68
- PFE 67.99
- Support Level
- COP $93.20
- PFE $25.14
- Resistance Level
- COP $96.92
- PFE $26.05
- Average True Range (ATR)
- COP 2.28
- PFE 0.42
- MACD
- COP 0.32
- PFE 0.10
- Stochastic Oscillator
- COP 83.37
- PFE 82.24
About COP ConocoPhillips
ConocoPhillips is a US-based independent exploration and production firm. In 2024, it produced 2.0 million barrels per day of oil and natural gas liquids and 3.4 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2024 were 7.8 billion barrels of oil equivalent.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.